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OBJECTIVE—Congenital hyperinsulinism in infancy (CHI) is
characterized by unregulated insulin secretion from pancreatic
b-cells; severe forms are associated with defects in ABCC8 and
KCNJ11 genes encoding sulfonylurea receptor 1 (SUR1) and
Kir6.2 subunits, which form ATP-sensitive K
+ (KATP) channels
in b-cells. Diazoxide therapy often fails in the treatment of CHI
and may be a result of reduced cell surface expression of KATP
channels. We hypothesized that conditions known to facilitate
trafﬁcking of cystic ﬁbrosis transmembrane regulator (CFTR)
and other proteins in recombinant expression systems might in-
crease surface expression of KATP channels in native CHI b-cells.
RESEARCH DESIGN AND METHODS—Tissue was isolated
during pancreatectomy from eight patients with CHI and from
adult cadaver organ donors. Patients were screened for muta-
tions in ABCC8 and KCNJ11. Isolated b-cells were maintained at
37°C or 25°C and in the presence of 1) phorbol myristic acid,
forskolin and 3-isobutyl-1-methylxanthine, 2) BPDZ 154, or 3)4 -
phenylbutyrate. Surface expression of functional channels was
assessed by patch-clamp electrophysiology.
RESULTS—Mutations in ABCC8 were detected for all patients
tested (n = 7/8) and included three novel mutations. In ﬁve of
eight patients, no changes in KATP channel activity were ob-
served under different cell culture conditions. However, in
three patients, in vitro recovery of functional KATP channels
occurred. Here, we report the ﬁrst cases of recovery of defec-
tive KATP channels in human b-cells using modiﬁed cell culture
conditions.
CONCLUSIONS—Our study establishes the principle that
chemical modiﬁcation of KATP channel subunit trafﬁcking could
be of beneﬁt for the future treatment of CHI. Diabetes 60:1223–
1228, 2011
C
ongenital hyperinsulinism in infancy (CHI) is
characterized by severe hypoglycemia, which
manifests in the neonatal period. The disease
may be limited to a localized region of the
pancreas (focal CHI) as a result of somatic loss of mater-
nal alleles and expression of paternal mutations or may be
diffuse and inherited with Mendelian genetics (1). The
most severe forms of CHI are caused by loss-of-function
mutations in the genes encoding the subunits of the ATP-
sensitive K
+ (KATP) channel: ABCC8 (encoding sulfonyl-
urea receptor 1 [SUR1]) and KCNJ11 (encoding Kir6.2);
both genes are located on chromosome 11p15 (1,2). In
b-cells, these channels are complexes consisting of four
SUR1 and four Kir6.2 subunits, which assemble in the
endoplasmic reticulum (ER) and are glycosylated and
modiﬁed as they pass through the cis-, medial-, and trans-
golgi network before being expressed at the cell surface.
Although studies of b-cells from patients with CHI have
proved the link between ABCC8 and KCNJ11 gene defects
and loss-of-function of KATP channels (3,4), recombinant
techniques have been used to further understand the
mechanisms of this loss. Disease-causing mutations engi-
neered in rodent SUR1 and Kir6.2 have been expressed in
mammalian and nonmammalian expression systems (e.g.,
COSm6 cell line, Xenopus oocytes) and found to cause
incorrect assembly of the channel complex, impaired
trafﬁcking from the ER, or loss of nucleotide regulation (4–
8). These experiments also demonstrated the importance
of speciﬁc amino acid motifs present on both SUR1 and
Kir6.2 for anterograde and retrograde trafﬁcking of KATP
channels (reviewed in [1,9]). Similar approaches have been
used to demonstrate that some CHI-related defects can be
overcome by altering the cell culture environment
(6,10,11). However, to date no studies have examined
methods to recover defective KATP channels in native
tissue, which could be of relevance in the future treat-
ment of CHI. We now report for the ﬁrst time rescue of
KATP channels in patient b-cells using chemical media-
tors, kinase activators, and reduced temperature.
RESEARCH DESIGN AND METHODS
Tissue was isolated (with permission) from cadaver human organ donors and
from eight patients with CHI who required subtotal pancreatectomy for in-
tractable hypoglycemia. Table 1 summarizes patient details. Islets of Langer-
hans were isolated as previously described (3,12). Total RNA was extracted
from islets and cells using TRIzol reagents (Invitrogen, Paisley, U.K.) and
subjected to RT-PCR using primers designed and tested in-house. All PCR
reactions consisted of an initial denaturation step of 94°C for 5 min followed
by 35 cycles of 94°C for 1 min, Ta°C for 1 min, and 72°C for 1 min followed by
From the
1Faculty of Life Sciences, University of Manchester, Manchester,
U.K.; the
2Department of Genetics, Groupe Hospitalier Pitié-Salpétrière,
Université Pierre et Marie Curie, Paris, France; the
3Institute of Biomedical
and Clinical Science, Peninsula Medical School, University of Exeter, Exe-
ter, U.K.; the
4Department of Pediatrics, Antwerp University Hospital, Uni-
versiteitsplein 1, Wilrijk, Antwerp, Belgium; the
5Institute of Child Health,
Great Ormond Street Hospital, London, U.K.; the
6Department of Endocri-
nology, Royal Manchester Children’s Hospital, Manchester, U.K.; and the
7Hôpital Necker Enfants Malades, Reference Centre of Metabolic Diseases,
Faculté de Médecine, Paris, France.
Corresponding author: Karen E. Cosgrove, karen.e.cosgrove@manchester.
ac.uk.
Received 12 October 2010 and accepted 28 January 2011.
DOI: 10.2337/db10-1443
 2011 by the American Diabetes Association. Readers may use this article as
long as the work is properly cited, the use is educational and not for proﬁt,
and the work is not altered. See http://creativecommons.org/licenses/by
-nc-nd/3.0/ for details.
diabetes.diabetesjournals.org DIABETES, VOL. 60, APRIL 2011 1223
BRIEF REPORTa ﬁnal elongation stage of 72°C for 10 min. For detection of mRNA encoding
KCNJ11 (Genbank Accession number NM_000525), primer sequences were as
follows: (F) ACA AGA ACA TCC GGG AGC, (R) ACA CGT AGC ATG AAG
CAG AGG with Ta 60°C. For detection of three different regions of ABCC8
(Genbank Accession number AF087138), primer sequences were as follows:
(F) AGA CTG CCC ACA AGA AGC (bases 748–765), (R) AGA AGA AAA ACC
ACA TGA (bases 1335–1317) with Ta 58°C; (F) GAC CCA CAA GCT ACA GTA
CC (bases 2693–2712), (R) CAC TCC ACA GTG ACA GAC G (bases 3295–3276)
with Ta 58°C; (F) TCT CGA ATA CAC AGA CTC C (bases 3713–3731), (R) ACA
GTG TGC TAT CTG AGC (bases 4386–4368) with Ta 60°C. PCR products were
resolved on 1.2% agarose gel prepared with Tris-borate EDTA buffer (Fisher
Scientiﬁc, Loughborough, U.K.) containing 1.2 mg/mL ethidium bromide
(Promega, Madison, WI). Bands were visualized and photographed under ul-
traviolet light.
Groups of dispersed islet cells were cultured at either 37°C or 25°C in
a humidiﬁed atmosphere of 5% CO2/air mixture for a minimum of 16 h with or
without addition of 10 mmol/L BPDZ 154 (B. Pirotte, Universite de Liege, Bel-
gium), 100 mmol/L diazoxide (Sigma, Poole, U.K.), or 2.5 mmol/L 4-phenylbutyrate
(4-PB) (Triple Crown America, Perkasie, PA). Alternatively, cells were in-
cubated for 1 h before experimentation at 37°C with 100 mmol/L 3-isobutyl-1-
methylxanthine (IBMX), 2 mmol/L forskolin, and 10 nmol/L phorbol myristic
acid (PMA; Sigma, Poole, U.K.). All data were obtained using the cell-attached
or inside-out recording conﬁgurations of the patch-clamp technique as pre-
viously described (3,12). In all experiments, the integrity of the recording
conﬁguration was assessed by inducing activation of the high conductance
Ca
2+- and voltage-gated K
+ channel by perfusing the inside face of the cell
membrane with a Ca
2+-containing solution (3,12). To select for KATP channel
currents, the pipette contained a standard NaCl-rich bathing solution con-
taining (in mol/L) 140 NaCl, 4.7 KCl, 2.5 CaCl2, 1.13 MgCl2, 10 HEPES, 2.5
glucose (pH 7.4 with NaOH), and the bath solution contained (in mol/L) 140
KCl, 10 NaCl, 1.13 MgCl2, 1 EGTA, 2.5 glucose, and 10 HEPES (pH 7.2 with
KOH) for all recordings. Reagents were added at the concentrations indicated
in the text. Diazoxide and BPDZ 154 were added to working solutions from
a stock solution dissolved in DMSO (Sigma) giving a ﬁnal concentration of less
than 0.1% vol/vol DMSO. Statistical comparisons were made using Student
t tests or ANOVA with values of P , 0.05 taken to be signiﬁcant. All data are
expressed as mean values 6 SEM.
RESULTS
In this study, insulin-secreting cells were investigated from
eight patients with CHI who underwent pancreatectomy
following failure to respond to medical treatment. Per-
mission for genotype analysis was obtained for seven
patients (#2–#8) and all were found to carry defects in
ABCC8 (Table 1; Fig. 2A). Genotyping was declined for
patient #1; therefore RNA was isolated from dispersed
islets and RT-PCR analysis for three regions of ABCC8,
and KCNJ11 carried out. Primers directed to discrete
regions of the N-terminus of ABCC8 and for KCNJ11
ampliﬁed appropriate products, but failed to do so when
primers were directed toward the center or COOH-terminal
regions of ABCC8 mRNA.
In isolated inside-out patches of membrane from control
human b-cells, KATP channels were spontaneously open and
activated in the presence of ATP by ADP (500 mmol/L) and
diazoxide (200 mmol/L) (Fig. 1A). In all eight CHI cases, we
found that SUR1 defects were linked to a functional loss of
KATP channels in b-cells since the average peak current
varied between patients from zero to approximately 10%
(n = 109 recordings) of the control values obtained from
human adult b-cells (n = 189). These data are similar to
our previously reported ﬁndings (3,4,12). Figure 1A (center
panel) shows typical recordings of b-cells from patient #1
when the cells were maintained under standard cell cul-
ture conditions (i.e., at 37°C without additional supple-
mentation of the tissue culture medium). In contrast with
control recordings, no operational or normally regulated
channels were recorded in either intact cells (n = 8/8) or
isolated inside-out patches (n = 8/8; Fig. 1A). However,
when b-cells from the patient were maintained at 25°C for
a minimum of 16 h, KATP channels were restored (n = 7/7)
and were found to be responsive to ADP and diazoxide
(Fig. 1A and B). This modiﬁcation did not affect the ac-
tivity of KATP channels in control human b-cells (Fig. 1C).
Following incubation at 25°C with 2.5 mmol/L 4-PB, no
further improvements were observed for patient #1 b-cells.
In contrast, we did see an increase in KATP channel activity
in ABCC8 (Arg998X/Ser1449dup) b-cells (patient #3)
maintained at 37°C with 4-PB. This procedure led to the
appearance of KATP channel currents, which were increased
by 4.4 ± 2-fold in 3/4 cells compared with control values, but
was not associated with the restoration of nucleotide-
dependent activation of channels (n = 3). Due to limited
tissue availability, we did not test effects of incubation at
25°C in patient #3 b-cells.
A similar pattern involving recovery of functional KATP
channel activity was found in ABCC8 (c.1467+5G.A)
b-cells (patient #2), ﬁrst when exposed to a combination
of IBMX (100 mmol/L), PMA (10 nmol/L), and forskolin
(2 mmol/L) for 1 h at 37°C immediately before the experi-
ment (n =4 / 4 ;F i g .1 D) and second when cells were main-
tained at 37°C for 24–48 h with BPDZ 154 (10 mmol/L)
added to the cell culture medium (n = 6/6; Fig. 1D). BPDZ
154-induced recovery of channel activity was also seen in
ABCC8 (Arg998X/Ser1449dup) b-cells (patient #3; n =4
recordings, 4.3 6 1-fold increase in activity), but this was
not associated with 0.5 mmol/L ATP-induced inhibition of
channels (n = 4).
DISCUSSION
In healthy b-cells, glucose-induced closure of KATP chan-
nels is a key regulator of stimulus-secretion coupling. The
TABLE 1
CHI patient tissue details
Patient (#) Age at surgery Histology Gene defect Genotype Reference
1 10 weeks Diffuse Presumed Homozygous, ABCC8 Unknown —
2 12 weeks Diffuse Homozygous, ABCC8 c.1467+5G.A Novel mutation
3 12 weeks Diffuse Compound Heterozygous, ABCC8 p.Arg998X/p.Ser1449dup 25
4 12 weeks Diffuse Homozygous, ABCC8 c.3992–9G.A3
5 7 weeks Diffuse Homozygous, ABCC8 c.3992–9G.A3
6 3.5 years Diffuse Compound Heterozygous, ABCC8 p.Gly70Glu/p.Arg1419Gly 3
7 12 months Diffuse Compound Heterozygous, ABCC8 p.Lys242fs/p.Arg1437X Novel mutations
8 4 weeks Focal Paternal uniparental isodisomy, ABCC8 p.Arg598X 3
Seven patients were found to have diffuse CHI, and one patient was deﬁned as focal CHI. Consent for genotyping was obtained from seven
patients, and all were found to carry defects in the ABCC8 gene. Islet mRNA was isolated from patient #1, and RT-PCR suggested that CHI was
caused by defects in ABCC8 expression and not KCNJ11. Where CHI causing mutations have been previously described, see references
indicated.
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1224 DIABETES, VOL. 60, APRIL 2011 diabetes.diabetesjournals.orgFIG. 1. In vitro recovery of KATP channels in CHI b-cells. A: Data from control (adult) human b-cells to illustrate the modulation of ATP-inhibited
channels (open probability [Po] = 0.03 6 0.02, n = 11 cells), by ADP (0.5 mol/L, Po = 0.1 6 0.03, n = 9) and diazoxide (0.2 mol/L, Po = 0.3 6 0.05,
n = 5) and from CHI b-cells maintained at either 37°C (standard conditions) or at 25°C. Note the marked increase in channel activity in CHI b-cells
maintained at low temperature and how ADP and diazoxide induce an increase in the activity of channels in the presence of ATP (0.5 mol/L). B:T h e
effects of cells maintained at 25°C on channel open probability. In CHI b-cells, no KATP channels were recorded under standard conditions (open
probability = 0, ■) but were readily observed in cells maintained at the lower temperature (◇). C: Maintaining control b-cells at 25°C had no
effect on the average magnitude of KATP channels in isolated patches (n = 7/7). D: The recovery of KATP channels in ABCC8 (c.1467+5G>A) b-cells
following short-term exposure to IBMX (0.1 mmol/L), forskolin (Fsk; 2 mmol/L), and PMA (10 nmol/L) for 1 h or long-term exposure to BPDZ 154
(10 mmol/L). Representative single-channel current data are shown alongside amplitude histogram proﬁles following Gaussian ﬁtting of the data
(smoothed lines). Note how in control b-cells >99% of the events occur at 0 pA (indicated by the dotted line) consistent with the absence of
functional channels, but that following treatment open events are apparent, which are sensitive to ATP (0.5 mmol/L).
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our understanding of how loss-of-function mutations in
ABCC8 or KCNJ11 cause CHI (1), whereas gain-of-function
mutations lead to neonatal diabetes (2). Gene defects that
render KATP channels less sensitive to ATP prevent correct
ATP:ADP sensing and can cause impaired insulin secretion
and diabetes (2). By contrast, decreased KATP channel
density and/or loss of ADP sensitivity is associated with
inappropriate electrical activity and uncontrolled insulin
release leading to CHI (3). Here we report recovery of
KATP channel activity in b-cells from patients with CHI
following incubation with chemical mediators, kinase
activators, and reduced temperature to increase trafﬁcking
of the channels to the cell membrane. In the ﬁeld of cystic
ﬁbrosis (CF) it has long been recognized that enhancement
of cell surface trafﬁcking of the defective ATP-binding
cassette (ABC) protein cystic ﬁbrosis transmembrane
regulator (CFTR) may be of therapeutic value (13). Most
CF patients (90%) carry a deletion of phenylalanine at
position 508 (DF508) of ABCC7, which encodes CFTR
(14). This mutation results in misfolding of the protein
leading to ER retention where it is subsequently poly-
ubiquitinated and targeted for degradation (15). Incubation
of cells engineered to express DF508 CFTR at 25°C was
found to result in recovery of CFTR activity by stabilizing
protein folding in the ER (16). We found that low tem-
perature incubation also led to recovery of mutant KATP
channel activity in CHI patient tissue. By analogy with
studies of the processing of mutant CFTR (16), we believe
that low temperature incubation of CHI b-cells stabilized
KATP channel subunits during folding and assembly in the
ER, and thereby allowed the protein to escape the ER
quality control measures. During the biogenesis of KATP
channels, it has recently been shown that SUR1 can in-
teract with heat shock cognate (HSC)70, heat shock pro-
tein (HSP)90, and HSP40 (17). We speculate that the
success of low temperature incubation arises through
disruption of mutant KATP channel degradation involving
HSC70, and this results in increased functional expression
of the channel at the cell membrane (Fig. 2B). We explored
this potential mechanism further using 4-PB, which
increases the trafﬁcking of mutant CFTR via down-
regulation of HSC70 expression (18). Similarly, in our
studies 4-PB also led to an increase in KATP channel ac-
tivity providing further support to the role of HSC70 in
degradation of mutant KATP channels (17).
In a separate set of experiments, we found that in-
cubation of CHI b-cells with a kinase activating cocktail
also led to KATP channel recovery. This effect could be due
to signaling pathways associated with activation of protein
kinase C, or the downstream effects of increased cytosolic
cAMP, such as activation of protein kinase A or other
cAMP-dependent signaling pathways including cAMP ki-
nase, A-kinase anchor proteins, cAMP regulatory element–
binding protein (CREB), and cAMP-regulated guanine nu-
cleotide exchange factors (cAMP-GEFs). Modulation of
kinase activity has previously been reported to increase
trafﬁcking of other ion channels and transporters such as
the bile salt export pump (also a member of the ABC pro-
tein family; 19), aquaporin-2 (20), and CFTR (21). It has also
been reported that PKC activation is associated with a re-
duction in surface KATP channel expression as a result of
a reduction in recycling of endocytic vesicles and the di-
version of KATP channel-containing vesicles to lysosomal
FIG. 2. KATP channel structure and trafﬁcking in b-cells. A: A consensus model of the structure of SUR1 (top) with predicted transmembrane
domains (numbered 1–17), extracellular NH2 terminus, and intracellular COOH terminus. Shaded rectangles represent the intracellular nucleotide
binding domains. Predicted sites of mutations for patient #3 are indicated (black stars); note that the intronic mutation c.1467+5G>5 does not
have a predicted site on SUR1. ○, known anterograde (forward) trafﬁcking motifs on SUR1; ●, the RKR retention motif, which must be masked by
correct channel assembly to permit forward trafﬁcking. The intron/exon structure of ABCC8 is shown below with shaded rectangles marking the
exons predicted to encode the nucleotide binding domains. B: The trafﬁcking of KATP channel proteins (black elipses) in b-cells. Gray arrows
indicate suggested mechanisms of compounds and conditions described in this study to increase forward trafﬁcking of KATP channels. PM, plasma
membrane; Endo, endosome; Lys, lysosome.
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vation in CHI b-cells suggests that activation of cAMP-
dependent kinases or similar mechanisms may have led
to increased expression or function of KATP channels
(Fig. 2B). Further studies are required to characterize
the precise signaling pathways involved.
Although diazoxide has previously been reported to in-
crease trafﬁcking of KATP channels in recombinant sys-
tems (6), the effects on trafﬁcking of the related compound
BPDZ 154, a more potent KATP channel agonist (12), have
not been investigated previously. In this study we found
that BPDZ 154 caused recovery of KATP channels in CHI
b-cells suggesting that the compound, like diazoxide, may
inﬂuence channel trafﬁcking in addition to opening KATP
channels. In recombinant cells several channel modulators
have now been reported to act as “chemical chaperones”
by mediating the recovery of defective channels (6,10),
including diabetes-causing mutations (11). Although the
mechanisms responsible for these actions have not been
fully investigated, the agents are thought to stabilize bio-
genesis of the channel complex rather than the SUR1
subunit and thereby facilitate ER exit of the complex. A
similar action may also explain the long-term effects of
BPDZ 154 on CHI b-cells (Fig. 2B).
Our series of experiments also included ﬁve cases of CHI
in which either short- or long-term modiﬁcation of the cell
culture conditions failed to evoke any increase in the
expression or regulation of KATP channels in CHI b-cells
(n = 51 experiments). This is not surprising since ABCC8
(or KCNJ11) defects will alter the protein in many dif-
ferent ways and not all will have conﬁgurations that en-
able the protein to be potentially liberated from the ER.
Indeed, in recombinant studies several ABCC8 mutations
have been shown to be resistant to chemical chaperones
(5,8,10).
Little is known about the effects of splice site mutations
in ABCC8 on the subsequent expression of SUR1 protein.
However, our results demonstrate that the presence of
splice-site mutations does not necessarily lead to the ab-
solute loss of channel protein since patients #4 and #5
demonstrated recordable (but defective) KATP channel
activity in untreated cells. We have no information on the
effects of the mutations reported in our study on tran-
scription and translation efﬁciency of the ABCC8 gene and
cannot therefore rule out that the culture conditions we
used somehow modiﬁed or stabilized these processes,
leading to apparent KATP channel recovery in some of our
experiments, including patient #2 b-cells expressing a splice
site mutation.
In summary, we have demonstrated rescue of KATP
channel activity for the ﬁrst time in pancreatic b-cells
isolated from patients with congenital hyperinsulinism.
Clinically, enhancement of mutant KATP channel trafﬁck-
ing to the cell membrane of b-cells could be beneﬁcial for
the treatment of CHI, especially if these channels retained
regulatory properties or could be activated by KATP chan-
nel agonists. With the introduction of rapid genetic testing
in CHI, pharmacogenomics is becoming increasingly re-
alistic for tailoring drug treatment to individuals. Therefore
it is possible that once the gene mutations causing CHI are
identiﬁed, optimization of trafﬁcking conditions for each
patient may permit successful enhancement of KATP
channel activity in some cases. By analogy with CF where
large scale screening efforts for small molecule “correc-
tors” of CFTR trafﬁcking have been successful (23), this
could eventually have an impact on clinical treatment of
CHI. Indeed, several pharmacological modulators of traf-
ﬁcking pathways are currently undergoing clinical trials
for the treatment of other diseases (24).
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